Filing Flows › Viatris (VTRS) › Recalls, complaints & regulation

Viatris (VTRS): recalls, clinical trials and Federal Register

Viatris (VTRS) beyond its filings: 2 recalls in the last 12 months (24 in five years, 1 Class I); 1 Federal Register document in a year; 9 active clinical trials.

Latest recalls

2026-10-28 · FDA drug · Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in I
2026-04-15 · FDA drug · Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in I
2025-01-22 · FDA drug · Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93
2025-01-22 · FDA drug · Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93
2024-12-18 · FDA drug · Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufacture
2024-12-18 · FDA drug · Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufacture
2024-12-18 · FDA drug · Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured
2024-12-18 · FDA drug · Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10), Rx only, Manufacture

Viatris' latest quarter

Viatris, Q3 2026: revenue $3.7B (-0.3% year over year), operating margin 7.0%, net loss $325M, operating cash flow $899M. The chart follows the revenue to costs, profit and cash.

Questions

Has Viatris had any recalls?

24 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.

How many clinical trials does Viatris have?

9 active studies on ClinicalTrials.gov, 6 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.